• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以尿素为标志物对鼻上皮衬液进行评估。

Estimation of nasal epithelial lining fluid using urea as a marker.

作者信息

Kaulbach H C, White M V, Igarashi Y, Hahn B K, Kaliner M A

机构信息

Allergic Diseases Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda 20892.

出版信息

J Allergy Clin Immunol. 1993 Sep;92(3):457-65. doi: 10.1016/0091-6749(93)90125-y.

DOI:10.1016/0091-6749(93)90125-y
PMID:8360397
Abstract

BACKGROUND

The luminal surface of respiratory mucous membranes is lined with an epithelial lining fluid (ELF) layer. Previous attempts to determine ELF volumes in airways have used dyes or freely diffusible molecules such as urea, yet have not led to a universally accepted method. The nasal mucous membrane provides an accessible area to examine whether urea is an appropriate marker of respiratory ELF volume.

METHODS AND RESULTS

Collection of undiluted nasal secretions after either glandular stimulation or induction of vascular permeability confirmed that plasma urea and nasal urea concentrations are equivalent. Baseline ELF volume was calculated as 800 microliters/nostril. The calculated molar concentrations of urea in ELF did not vary with either methacholine or histamine challenge.

CONCLUSIONS

These data indicate the plasma, interstitial, glandular, and ELF urea concentrations are equivalent and, therefore, that urea is a useful marker of ELF volume in the nasal mucosa.

摘要

背景

呼吸道黏膜的腔面衬有一层上皮衬液(ELF)。以往测定气道中ELF容量的尝试使用了染料或尿素等可自由扩散的分子,但尚未形成一种被普遍接受的方法。鼻黏膜提供了一个可用于检验尿素是否为呼吸道ELF容量合适标志物的可及区域。

方法与结果

在腺体刺激或诱导血管通透性后收集未稀释的鼻分泌物,证实血浆尿素和鼻尿素浓度相等。基线ELF容量计算为每侧鼻孔800微升。计算得出的ELF中尿素的摩尔浓度在乙酰甲胆碱或组胺激发试验中均无变化。

结论

这些数据表明血浆、间质、腺体和ELF中的尿素浓度相等,因此尿素是鼻黏膜中ELF容量的有用标志物。

相似文献

1
Estimation of nasal epithelial lining fluid using urea as a marker.以尿素为标志物对鼻上皮衬液进行评估。
J Allergy Clin Immunol. 1993 Sep;92(3):457-65. doi: 10.1016/0091-6749(93)90125-y.
2
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.使用尿素作为稀释标志物通过灌洗回收的上皮衬液体积的估计。
J Appl Physiol (1985). 1986 Feb;60(2):532-8. doi: 10.1152/jappl.1986.60.2.532.
3
Solute exchange between the plasma and epithelial lining fluid of rat lungs.大鼠肺脏血浆与上皮衬液之间的溶质交换。
J Appl Physiol (1985). 1992 Mar;72(3):1081-9. doi: 10.1152/jappl.1992.72.3.1081.
4
Quantitative assessment of epithelial lining fluid in the lung.肺上皮衬液的定量评估。
Am J Physiol. 1992 Dec;263(6 Pt 1):L617-8. doi: 10.1152/ajplung.1992.263.6.L617.
5
Determination of low-molecular-mass antioxidant concentrations in human respiratory tract lining fluids.人体呼吸道内衬液中低分子量抗氧化剂浓度的测定
Am J Physiol. 1999 Feb;276(2):L289-96. doi: 10.1152/ajplung.1999.276.2.L289.
6
Proposal of membrane transport mechanism of protein-unbound ulifloxacin into epithelial lining fluid determined by improved microdialysis.通过改进的微透析法测定蛋白结合型乌利沙星进入上皮衬液的膜转运机制的研究方案。
Biol Pharm Bull. 2008 Sep;31(9):1773-7. doi: 10.1248/bpb.31.1773.
7
Epithelial lining fluid solute concentrations in chronic obstructive lung disease patients and normal subjects.慢性阻塞性肺疾病患者和正常受试者的上皮衬液溶质浓度。
J Appl Physiol (1985). 2005 Oct;99(4):1286-92. doi: 10.1152/japplphysiol.00362.2005. Epub 2005 May 26.
8
Human nasal mucosal carboxypeptidase: activity, location, and release.人鼻黏膜羧肽酶:活性、定位与释放
J Allergy Clin Immunol. 1995 Dec;96(6 Pt 1):924-31. doi: 10.1016/s0091-6749(95)70230-x.
9
Novel applications for a noninvasive sampling method of the nasal mucosa.鼻黏膜无创采样方法的新应用。
Am J Physiol Lung Cell Mol Physiol. 2017 Feb 1;312(2):L288-L296. doi: 10.1152/ajplung.00476.2016. Epub 2016 Dec 23.
10
[Usefulness of the urea method in nasal discharge analysis].[尿素法在鼻分泌物分析中的应用价值]
Nihon Jibiinkoka Gakkai Kaiho. 2000 Jun;103(6):734-41. doi: 10.3950/jibiinkoka.103.734.

引用本文的文献

1
Development and validation of a LC-MS/MS method for the simultaneous determination of simnotrelvir and ritonavir in human serum and bronchoalveolar lavage fluid.用于同时测定人血清和支气管肺泡灌洗液中西莫瑞韦和利托那韦的液相色谱-串联质谱法的开发与验证。
BMC Chem. 2025 Jul 2;19(1):180. doi: 10.1186/s13065-025-01534-x.
2
Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial.每日鼻内注射帕利珠单抗预防健康早产儿呼吸道合胞病毒感染:一项1/2b期随机安慰剂对照试验。
EClinicalMedicine. 2023 Nov 25;66:102324. doi: 10.1016/j.eclinm.2023.102324. eCollection 2023 Dec.
3
Rhinorrhea and increased chloride secretion through the CFTR chloride channel-a systematic review.
通过 CFTR 氯离子通道导致的鼻分泌物增多和氯离子分泌增加——系统评价。
Eur Arch Otorhinolaryngol. 2023 Oct;280(10):4309-4318. doi: 10.1007/s00405-023-08067-w. Epub 2023 Jun 20.
4
Multiplex Hybrid Antigen-Capture LC-MRM Quantification in Sera and Nasal Lining Fluid of AZD7442, a SARS-CoV-2-Targeting Antibody Combination.AZD7442(一种靶向 SARS-CoV-2 的抗体组合)在血清和鼻黏膜液中的多重混合抗原捕获 LC-MRM 定量分析。
Anal Chem. 2022 Nov 1;94(43):14835-14845. doi: 10.1021/acs.analchem.2c01320. Epub 2022 Oct 21.
5
Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals.成年健康个体鼻分泌物和血浆中激肽肽谱变化的质谱研究。
J Transl Med. 2022 Mar 29;20(1):146. doi: 10.1186/s12967-022-03332-8.
6
Topical TMPRSS2 inhibition prevents SARS-CoV-2 infection in differentiated human airway cultures.局部抑制 TMPRSS2 可预防人呼吸道分化细胞中 SARS-CoV-2 的感染。
Life Sci Alliance. 2022 Feb 2;5(4). doi: 10.26508/lsa.202101116. Print 2022 Apr.
7
An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates.一种基于腺相关病毒的、室温稳定的、单剂量 COVID-19 疫苗在非人类灵长类动物中提供了持久的免疫原性和保护作用。
Cell Host Microbe. 2021 Sep 8;29(9):1437-1453.e8. doi: 10.1016/j.chom.2021.08.002. Epub 2021 Aug 7.
8
Intranasal gene therapy to prevent infection by SARS-CoV-2 variants.经鼻内基因治疗预防 SARS-CoV-2 变异株感染。
PLoS Pathog. 2021 Jul 15;17(7):e1009544. doi: 10.1371/journal.ppat.1009544. eCollection 2021 Jul.
9
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates.中和抗体LY-CoV555可保护非人类灵长类动物免受SARS-CoV-2感染。
Sci Transl Med. 2021 May 12;13(593). doi: 10.1126/scitranslmed.abf1906. Epub 2021 Apr 5.
10
Airways exudation of plasma macromolecules: Innate defense, epithelial regeneration, and asthma.气道渗出的血浆大分子:先天防御、上皮再生和哮喘。
J Allergy Clin Immunol. 2019 Apr;143(4):1271-1286. doi: 10.1016/j.jaci.2018.07.037. Epub 2018 Aug 29.